TABLE 1

Patient Characteristics

Patient no.	Age (y)	iPSA (ng/mL)	Prostate volume (mL)	Days from mpMRI to surgery	Days from PSMA PET/CT to surgery	Histopathology TNM staging	Gleason-score/WHO group	Tumor volume (percentage of the whole prostate)	PCa SUV_max (1 h after injection)	PCa SUV_max (3 h after injection)	Normal tissue SUV_max
1	77	40.0	50	54	21	pT3b, pN1(4/14), L1, V0, Pn1, R1	4 + 5 = 9/5	30%	54.9	76.2	2.8
2	55	14.0	66	97	38	pT3b, pN1(5/40), L1, V0, Pn1, R1	4 + 5 = 9/5	45%	10.9	14.8	NA
3	65	13.9	52	193	56	pT3b, pN1(1/41), L0, V0, Pn1, RX	4 + 5 = 9/5	10%	24.3	30.2	2.7
4	64	10.0	40	116	1	pT3b, pN1(3/48), L1, V0, Pn1, R1	4 + 5 = 9/5	35%	18.9	27.5	2.9
5	64	12.2	23	66	19	pT3a, pN1(3/57), L1, V1, Pn1, R1	4 + 3 = 7b/3	10%	13.0	22.6	2.9
6	62	8.5	26	73	3	pT3a, pN0(0/21), L0, V0, Pn1, R1	3 + 4 = 7a/2	15%	15.5	27.5	3.6
7	69	5.8	50	147	26	pT3a, pN0(0/32), L0, V0, Pn0, R0	4 + 5 = 9/5	15%	36.7	58.6	3.0
8	73	31.0	47	——–	6	pT3a, pN0(0/27), L0, V0, Pn1, R1	3 + 4 = 7a/2	30%	16.3	19.6	3.5
9	76	16.8	100	105	21	pT2c, pN1(3/40), L1, V0, Pn1, R0	4 + 5 = 9/5	20%	10.6	——–	2.5
10	72	11.2	49	61	26	pT3b, pN1(5/61), L1, V0, Pn1, R1	4 + 5 = 9/5	70%	15.5	20.3	NA